Biotroniks issue is not product, its leadership and management. They have as good or better product than any other CRM company worldwide. If you disagree, then you are a fool. Their leadership and managements vision is myopic at best. They always go for the cheap fix and think in get rich quick mentalities. They struck peverbial gold in Vegas-SoCal initially and thought they could replicate it in the PNW, MW, NorCal with disasterous results that will take years to heal. The rest of the country is similar in thinking but a different structure. They continue to pursue a business model that consists of luring tenured reps with a few established relationships who follow, but usually as much or more baggage. Short term bump but long term dwindling of base business. Sort of like chasing the tail linerarly with no vision of progress. So much time is spent putting out fires, issues w independant boondoggles that progress cannot be achieved. They also support the business with strategies of training sites and clinical studies offered as inducements.
As a competitor, I would do my best to support their poor business strategy by offering as little resistance as posible to their hiring practices by "stealing" moderately sucessful reps looking for a cash grab. Perfect example is in Long Island. Essentially a purge of stagnent talent which allows STJ to progress. Bio will never succeed unless major leadership changes from the top down as well as sales managers who actually hold indpendants accountable for illegal sales practices.
If similar tactics are engaged for the creation of a coronary sales force, no matter how good the product is, they will never be a true market leader. Hospitals will never allign with them on dual vendor contracts either. Not to mention the whole "investigation" either. It will not be cheap and they wont be able to buy their way out of it as the big dogs have in the past.
